GLOBUS MEDICAL INC — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 18/100
What the filing says
This filing presents the amended 2021 Equity Incentive Plan for Globus Medical. The Plan authorizes up to 12,000,000 shares for equity grants (options, RSUs, restricted stock, performance awards, SARs) to employees, directors, and consultants, plus any unused shares from the predecessor 2012 Plan. The document contains standard plan mechanics: option exercise prices at 100% fair market value, 1-year minimum vesting, change-of-control provisions, and administrative procedures. No new share authorization or material terms change is disclosed in the exhibits provided.
Why this rating
Boilerplate equity plan document. 12M shares (~0.5% of $6.6B market cap at typical stock price) is routine overhead. No new material transaction, deal, or disclosure.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.